(Q53441599)

14 May 2018

title

Interleukin-6 functions as an autocrine growth factor in human bladder carcinoma cell lines in vitro. (English)

1 reference

14 May 2018

0 references

1 reference

M Okamoto

1

1 reference

14 May 2018

K Hattori

series ordinal

2

1 reference

14 May 2018

R Oyasu

series ordinal

3

1 reference

14 May 2018

language of work or name

English

0 references

publication date

1 July 1997

1 reference

14 May 2018

International Journal of Cancer

published in

1 reference

14 May 2018

volume

72

1 reference

14 May 2018

page(s)

149-154

1 reference

14 May 2018

issue

1

1 reference

14 May 2018

Cytokine production by the human bladder carcinoma cell line T24 in the presence of bacillus Calmette-Guerin (BCG).

cites work

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819970703%2972%3A1%3C149%3A%3AAID-IJC21%3E3.0.CO%3B2-D

Interleukin-6 (IL-6) functions as an autocrine growth factor in cervical carcinomas in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819970703%2972%3A1%3C149%3A%3AAID-IJC21%3E3.0.CO%3B2-D

Interleukin-6 undergoes transition from paracrine growth inhibitor to autocrine stimulator during human melanoma progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819970703%2972%3A1%3C149%3A%3AAID-IJC21%3E3.0.CO%3B2-D

Bladder cancer. Human leukocyte antigen II, interleukin-6, and interleukin-6 receptor expression determined by the polymerase chain reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819970703%2972%3A1%3C149%3A%3AAID-IJC21%3E3.0.CO%3B2-D

Effect of transfected interleukin-6 in non-tumorigenic and tumorigenic rat urothelial cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819970703%2972%3A1%3C149%3A%3AAID-IJC21%3E3.0.CO%3B2-D

B cell growth and differentiation induced by supernatants of transformed epithelial cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819970703%2972%3A1%3C149%3A%3AAID-IJC21%3E3.0.CO%3B2-D

Interleukin 6 decreases cell-cell association and increases motility of ductal breast carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819970703%2972%3A1%3C149%3A%3AAID-IJC21%3E3.0.CO%3B2-D

Cloning and expression of the human interleukin-6 (BSF-2/IFN beta 2) receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819970703%2972%3A1%3C149%3A%3AAID-IJC21%3E3.0.CO%3B2-D

Interleukin-6 (IL-6) functions as an in vitro autocrine growth factor in renal cell carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819970703%2972%3A1%3C149%3A%3AAID-IJC21%3E3.0.CO%3B2-D

Growth and characterization of normal human urothelium in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819970703%2972%3A1%3C149%3A%3AAID-IJC21%3E3.0.CO%3B2-D

Interleukin-6 activity in urine and serum in patients with bladder carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819970703%2972%3A1%3C149%3A%3AAID-IJC21%3E3.0.CO%3B2-D

Enhanced Expression of Interleukin-6 in Primary Human Renal Cell Carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819970703%2972%3A1%3C149%3A%3AAID-IJC21%3E3.0.CO%3B2-D

10.1002/(SICI)1097-0215(19970703)72:1<149::AID-IJC21>3.0.CO;2-D

21 January 2018

Identifiers

DOI

1 reference

14 May 2018

PubMed ID

9212236

1 reference

14 May 2018